A carregar...
Comparative Effectiveness of Vedolizumab vs. Infliximab Induction Therapy in Ulcerative Colitis: Experience of a Real-World Cohort at a Tertiary Inflammatory Bowel Disease Center
BACKGROUND: Vedolizumab (VDZ), an adhesion molecule inhibitor and infliximab (IFX), a tumor necrosis factor (TNF) blocker, are both approved as first-line induction agents in moderately to severely active ulcerative colitis (UC). However, there are no head-to-head studies comparing the relative effe...
Na minha lista:
| Publicado no: | Gastroenterology Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elmer Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5827901/ https://ncbi.nlm.nih.gov/pubmed/29511405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/gr934w |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|